Cargando…
Effects of perhexiline-induced fuel switch on the cardiac proteome and metabolome
Perhexiline is a potent anti-anginal drug used for treatment of refractory angina and other forms of heart disease. It provides an oxygen sparing effect in the myocardium by creating a switch from fatty acid to glucose metabolism through partial inhibition of carnitine palmitoyltransferase 1 and 2....
Autores principales: | Yin, Xiaoke, Dwyer, Joseph, Langley, Sarah R., Mayr, Ursula, Xing, Qiuru, Drozdov, Ignat, Nabeebaccus, Adam, Shah, Ajay M., Madhu, Basetti, Griffiths, John, Edwards, Lindsay M., Mayr, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573230/ https://www.ncbi.nlm.nih.gov/pubmed/23277191 http://dx.doi.org/10.1016/j.yjmcc.2012.12.014 |
Ejemplares similares
-
Proteomics: from single molecules to biological pathways
por: Langley, Sarah R., et al.
Publicado: (2013) -
Metabolic homeostasis is maintained in myocardial hibernation by adaptive changes in the transcriptome and proteome
por: Mayr, Manuel, et al.
Publicado: (2011) -
Profiling of circulating microRNAs: from single biomarkers to re-wired networks
por: Zampetaki, Anna, et al.
Publicado: (2012) -
Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation
por: Dhakal, Bimala, et al.
Publicado: (2023) -
Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms
por: Zervou, Sevasti, et al.
Publicado: (2016)